← Back to Search

Visual Stimulation for Vision Attention

N/A
Recruiting
Led By Martina Poletti, Ph.D.
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0
Awards & highlights

Study Summary

This trial is testing the hypothesis that attention, like eye movements, can be controlled at the foveal level. To do this, they are conducting various visual tasks with human subjects while tracking their eye movements.

Who is the study for?
This trial is for adults over 18 with perfect vision (20/20) without glasses or contacts, who speak English and can understand the study. They must read, understand, and sign a consent form. People under 18, those who need vision correction or have known visual deficits that fail an eye chart test are excluded.Check my eligibility
What is being tested?
The study tests how small involuntary eye movements during fixation affect attention and visual perception. It uses high-resolution eyetracking and real-time visual stimuli adjustments to examine participants' performance in tasks requiring discrimination/detection of visuals within the fovea.See study design
What are the potential side effects?
Since this research involves non-invasive procedures like eyetracking and visual stimulation, there are no direct side effects associated with these interventions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average Performance in Visual tasks
Secondary outcome measures
Microsaccades rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: Normal VisionExperimental Treatment1 Intervention
This study examines high-acuity vision, oculomotor behavior recorded using high-resolution eyetracking. Healthy participants are asked to perform different types of visual tasks, ranging from letter identification to judging facial expressions while their eye movements will be recorded with high-precision together with their behavioral performance in the task.

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
831 Previous Clinical Trials
516,596 Total Patients Enrolled
National Eye Institute (NEI)NIH
546 Previous Clinical Trials
1,403,388 Total Patients Enrolled
1 Trials studying Vision
180 Patients Enrolled for Vision
Martina Poletti, Ph.D.Principal Investigator - University of Rochester
University of Rochester

Media Library

Visual stimulation Clinical Trial Eligibility Overview. Trial Name: NCT03884985 — N/A
Vision Research Study Groups: Normal Vision
Vision Clinical Trial 2023: Visual stimulation Highlights & Side Effects. Trial Name: NCT03884985 — N/A
Visual stimulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT03884985 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit to participant recruitment for this research project?

"Affirmative, the information on clinicaltrials.gov specifies that this trial is actively enrolling participants. The investigation was first uploaded on January 1st 2018 and has been modified as recently as March 1st 2022. Currently 50 volunteers are needed from a single location."

Answered by AI

Are there opportunities for prospective participants to join this experiment?

"Clinicaltrials.gov confirms that this medical study, initially posted on January 1st 2018 and recently edited on March 1st 2022, is actively enrolling patients."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
University of Rochester
What portion of applicants met pre-screening criteria?
Met criteria
~7 spots leftby Mar 2025